GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianhai Health Holdings Ltd (HKSE:00911) » Definitions » Days Sales Outstanding

Qianhai Health Holdings (HKSE:00911) Days Sales Outstanding : 0.00 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Qianhai Health Holdings Days Sales Outstanding?

Qianhai Health Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was HK$0.0 Mil. Qianhai Health Holdings's Revenue for the six months ended in Dec. 2023 was HK$621.4 Mil. Hence, Qianhai Health Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Qianhai Health Holdings's Days Sales Outstanding or its related term are showing as below:

HKSE:00911' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.96   Med: 97.48   Max: 192.14
Current: 0.96

During the past 11 years, Qianhai Health Holdings's highest Days Sales Outstanding was 192.14. The lowest was 0.96. And the median was 97.48.

HKSE:00911's Days Sales Outstanding is ranked better than
99.6% of 999 companies
in the Drug Manufacturers industry
Industry Median: 71.7 vs HKSE:00911: 0.96

Qianhai Health Holdings's Days Sales Outstanding declined from Dec. 2022 (0.61) to Dec. 2023 (0.00).


Qianhai Health Holdings Days Sales Outstanding Historical Data

The historical data trend for Qianhai Health Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianhai Health Holdings Days Sales Outstanding Chart

Qianhai Health Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 87.68 107.34 192.14 10.00 0.96

Qianhai Health Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 317.15 15.94 0.61 1.36 -

Competitive Comparison of Qianhai Health Holdings's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Qianhai Health Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qianhai Health Holdings's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianhai Health Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Qianhai Health Holdings's Days Sales Outstanding falls into.



Qianhai Health Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Qianhai Health Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2.53 + 0) / 1 ) / 961.291*365
=2.53 / 961.291*365
=0.96

Qianhai Health Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (0 + 0) / 1 ) / 621.392*365 / 2
=0 / 621.392*365 / 2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qianhai Health Holdings  (HKSE:00911) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Qianhai Health Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Qianhai Health Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Qianhai Health Holdings (HKSE:00911) Business Description

Traded in Other Exchanges
N/A
Address
177-183 Wing Lok Street, Room 301-3, 3rd Floor, Wing Tuck Commercial Centre, Sheung Wan, Hong Kong, HKG
Qianhai Health Holdings Ltd principally engaged in the sale of health products and electronic component products. It includes Chinese herbal medicines, skin-care and other healthcare products and the sale of information technology components products. The operating segments of the group are Healthcare products and Electronic component products. Healthcare products includes sale of healthcare products including Chinese herbal medicines, skincare and other healthcare products. Electronic component products includes sale of information technology components products including central processing unit and semiconductors. The group's revenue is all derived from Hong Kong.
Executives
Huang Guanchao 2101 Beneficial owner
Shinewing Sas (nominee Services) No. 3 Limited 2501 Other
Hou Chung Man 2501 Other
Tang Chung Wah 2501 Other
Sparkling Rock Limited 2201 Interest of corporation controlled by you
Chong Siew Hoong 2202 Interest of your spouse
Lim Tzea 2101 Beneficial owner
Explorer Rosy Limited
Great Prosperous Limited
Noble Stand Global Limited
Thousands Beauties Limited
Yunnan Energy Investment (h K) Co. Limited 2106 Person having a security interest in shares
Yunnan International Holding Group Limited 2106 Person having a security interest in shares
Yunnan International Supply Chain Limited 2106 Person having a security interest in shares
Yunnan Provincial Energy Investment Group Co., Ltd 2106 Person having a security interest in shares

Qianhai Health Holdings (HKSE:00911) Headlines

No Headlines